| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | -91.1% |
| R&D Expense | $115.9M | -4.9% |
| SG&A Expense | $50.5M | +9.6% |
| Operating Income | -$162.7M | -28.1% |
| Pre-tax Income | -$161.1M | -31.6% |
| Income Tax | $681K | +433.8% |
| Net Income | -$161.8M | -32.4% |
| EPS (Basic) | -$2.05 | +13.1% |
| EPS (Diluted) | -$2.05 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $88.5M | -41.2% |
| Current Assets | $98.5M | -39.4% |
| Total Assets | $146.4M | -29.3% |
| Current Liabilities | $71.5M | +11.4% |
| Total Liabilities | $183.6M | +10.2% |
| Stockholders' Equity | -$45.1M | -238.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$127.8M | -43.6% |
| Capital Expenditures | $1.4M | +143.0% |
| Investing Cash Flow | -$1.3M | -124.1% |
| Financing Cash Flow | $67.2M | +20.3% |
| Free Cash Flow | -$129.1M | -44.2% |
| +13.1% |